Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 31, 2019

SELL
$35.43 - $56.29 $11.5 Million - $18.2 Million
-324,063 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$44.22 - $75.47 $11.3 Million - $19.2 Million
-254,778 Reduced 44.02%
324,063 $18.5 Million
Q2 2018

Aug 02, 2018

SELL
$72.38 - $92.5 $3.04 Million - $3.88 Million
-41,972 Reduced 6.76%
578,841 $46.2 Million
Q1 2018

Apr 30, 2018

BUY
$69.46 - $88.57 $4.62 Million - $5.89 Million
66,530 Added 12.0%
620,813 $53.8 Million
Q4 2017

Jan 31, 2018

BUY
$65.94 - $93.31 $4.11 Million - $5.81 Million
62,295 Added 12.66%
554,283 $38.3 Million
Q3 2017

Oct 31, 2017

BUY
$80.87 - $91.08 $39.8 Million - $44.8 Million
491,988
491,988 $44.7 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $151M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.